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workshop on intracellular bacteria: from biology to clinic”, that we submit as an 
article in Microbes and Infection.  
 
In this meeting report, we present the main events that took place during this meeting 
and describes main scientific presentations. 
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version of the manuscript has been seen and accepted by both authors. We hope that 
this original work will fall within the scope of your Journal. 
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Abstract 32 
 Infection by intracellular bacteria can lead to several diseases in both veterinary and 33 
human medicine. Unfortunately, the biology of these intracellular bacteria is highly complex 34 
due to their interactions with their host cells. Thus, it is very important to develop several tools 35 
in order to better understand the complex intracellular life of these pathogens, so allowing to 36 
improve the diagnosis options and the treatments of infectious diseases that they are causing. 37 
The workshop organised in Villars-sur-Ollon (Switzerland) by the ESCMID Study group on 38 
intracellular bacteria was a good opportunity to enhance our knowledge on these fastidious 39 
pathogens. During 5 days, 15 speakers gave 41 talks, covering all fields, from biology to clinic of 40 
different intracellular bacteria such as Bartonella, Chlamydia, Coxiella, Ehrlichia, Listeria, 41 
Parachlamydia, Risckettsia, and Waddlia. The format of this postgraduate course, which took 42 
place in the Swiss mountains, allowed interactive sessions and living discussions between the 43 
participants coming from all around the world. One of the major strength was to gather 44 
epidemiologists, clinical microbiologists, infectious diseases specialists, entomologists, 45 
veterinarians as well as bioinformaticians, biochemists and biologists to deliver a unique "one-46 
health science" on intracellular bacteria. Here, we summarize the main take-home messages 47 
delivered during this meeting. 48 
 49 
 50 
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 55 
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 58 
 59 
 60 
 61 
 62 
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Main text 64 
 65 
1) Introduction 66 
Obligate intracellular bacteria, such as Chlamydia, Rickettsia and Coxiella, have to infect 67 
their eukaryotic host in order to survive. Some of them are able to infect a wide range of hosts 68 
and some may even cause an infectious disease. These infections can be asymptomatic but in 69 
most cases, they result in significant deleterious effects for the host, often associated with 70 
significant mortality and morbidity. Due to the difficulty to detect obligate intracellular 71 
bacteria, they have been often described for the first time during outbreaks. Thus, some 72 
intracellular bacteria are likely yet unknown whereas others are still only considered as 73 
emerging pathogens since it is difficult to confirm their pathogenic role. Moreover, despite 74 
significant pathogenicity of several intracellular bacteria, they are still poorly studied. Indeed, 75 
due to the historical lack of genetic tools, and due to the need of cell culture, it is very difficult 76 
to study their strict intracellular lifestyle and to precise the virulence factors involved in their 77 
pathogenesis. Fortunately, several people are working in this field and try to better understand 78 
the biology of intracellular bacteria and the pathogenic mechanisms that are at play.  79 
The ESCMID study group for intracellular bacteria (ESCAR) is currently composed of 80 
approximately 300 members, including physicians, microbiologists, veterinarians, and other 81 
specialists, interested in the biology, epidemiology, and pathogenicity of Coxiella, Ehrlichia, 82 
Anaplasma, Rickettsia, Bartonella, Chlamydia and Chlamydia-related bacteria. Since the aim of 83 
ESCAR is to encourage basic and applied research in the field of intracellular bacteria and 84 
related diseases, ESCAR regularly organise postgraduate courses.  85 
Thus, an ESCMID postgraduate workshop was organised by Pr. Gilbert GREUB in Villars-sur-86 
Ollon, in Switzerland, from 26 to 30 August 2013, and it was entitled "Intracellular Bacteria: 87 
From Biology to Clinic". This workshop gathered 55 participants and included interactive 88 
sessions, fostering living discussions and a high level of interaction and cooperation about our 89 
shared fascinating interest, intracellular bacteria. During this workshop, the sessions 90 
alternated between i) biology, with talks about the pathogenesis, molecular biology, genomics 91 
and cell biology of intracellular bacteria, and ii) medicine, with talks about clinical 92 
presentation, diagnostic approaches, epidemiology and treatment of infections caused by 93 
obligate intracellular bacteria. 94 
 95 
 96 
 97 
2) Participants and venue 98 
The workshop on intracellular bacteria, with 55 participants coming from 21 countries, 99 
was organised in Villars-sur-Ollon, in the beautiful scenery offered by the Swiss Alps. The 100 
parity was appropriate during this postgraduate course, with 30 men and 25 women, and with 101 
people coming from all around the world. Majority of the participants were from European 102 
countries, but some people made a long trip, such as 2 investigators from Korea, 3 from 103 
Australia, 1 from India, 1 from Sri Lanka, 2 from Tunisia and 1 from USA. The atmosphere was 104 
very relaxed and friendly between all participants, allowing fruitful discussions and 105 
interactions, particularly during the lunch and diner breaks around delicious specialities like 106 
the famous Swiss Raclette (Fig.1).  This week of scientific presentations on intracellular 107 
bacteria was brighten up by an afternoon of hiking in the pastures, allowing also to know each 108 
other better (Fig.1). For the most motivated people, a jogging session was organised all 109 
morning and it was also very nice to discuss and to have the opportunity to create some 110 
collaborations in parallel to non-scientific activities (Fig.1). The last day, it was time to come 111 
down again to the lemanic area, since this day was dedicated to the practical session organised 112 
in Lausanne at the University Hospital and at the Institute of Microbiology of the University. 113 
The practicals represented a good opportunity for all participants, distributed in small groups 114 
of 5 persons, to discover some techniques used to study intracellular bacteria, and/or to 115 
improve their practical skills (see below). 116 
 117 
3) Epidemiology 118 
The workshop was opened by the chairman of ESCAR, Pr. Amel Letaief, and by the 119 
organizer, Pr. Gibert Greub. During the first afternoon, talks focused on the epidemiology of 120 
infections caused by three different obligate intracellular bacteria: Rickettsia, Coxiella and 121 
Chlamydia.  122 
P.E. Fournier (Marseille, France) started this session with an overview of Rickettsia present 123 
around the world. Rickettsia are intracellular bacteria widely distributed and vectorized by 124 
arthropods such as ticks, fleas and body lice. These bacteria are human pathogens, which may 125 
cause either a spotted fever rickettsial infection or the typhus. As underlined by P.E. Fournier, 126 
the dogma associating a given rickettsiosis to a given arthropod vector is false, since exceptions 127 
may commonly occur and geographic repartition of rickettsiosis has been recently redefined 128 
[1]. Arthropods are key vectors for Rickettsia but could also be vectors of others intracellular 129 
bacteria. This hypothesis was formulated by A. Croxatto (Lausanne, Switzerland) that reported 130 
the results of its project investigating the transmission of Chlamydia and Chlamydia-related 131 
bacteria by arthropods. Thanks to a new pan-Chlamydiales PCR, Croxatto et al. showed the high 132 
prevalence (30 to 45 %) of Chlamydiles present in ticks collected in Switzerland and in Algeria 133 
(Croxatto et al. in press). Thus, arthropods and more specifically the ticks, already known as 134 
vector for Rickettsiales, seem to also act as a reservoir and possibly as a vector for some 135 
Chlamydia-related bacteria. This is important since human and animals are commonly exposed 136 
to ticks. Small ruminants are particularly susceptible to chlamydial and rickettsial infections 137 
[2]. D. Longbottom (Edinburgh, UK) focused his talk on five strict intracellular bacteria: (i) 138 
Ehrlichia ruminatum responsible for Heartwater, (ii) Anaplasma ovis and (iii) Anaplasma 139 
phagocytophilum responsible for Anaplasmosis and Tick-borne fever respectively, (iv) Coxiella 140 
burnetii responsible for Q fever, and finally (v) Chlamydia abortus responsible for ovine 141 
chlamydiosis. These five ovine infectious diseases were described in details including clinical 142 
pictures, and approaches used for their diagnosis and treatment options in the veterinarian 143 
field. The zoonotic risk was also addressed, being thus an excellent introduction for the second 144 
part of the afternoon sessions dedicated to three Coxiella outbreaks. 145 
The prevalence of the Q fever is very low in Switzerland but one of the largest Coxiella 146 
outbreaks ever described worldwide occurred in 1983 in the "Val de Bagnes", a few dozen of 147 
kilometres away from the meeting venue. Up to 415 persons were infected, as underlined by O. 148 
Peter (Sion, Switzerland). The source of the outbreak was sheep flocks coming from alpine 149 
pastures [3]. More recently, another small outbreak was reported in Lavaux (Switzerland), and 150 
G. Greub (Lausanne, Switzerland), who presented this topic, stressed the importance of the fast 151 
implementation of different public health measures in order to impact favourably the outcome 152 
of outbreaks. Indeed, rapid implementation of public health measures may explain why the 153 
outbreak remained limited to only 14 human cases (Bellini et al. New microbes and new 154 
infections, in press). Unfortunately, outbreaks do not always have such a favourable issue and 155 
may last for years. This is the case of the huge Q fever epidemic that started in Netherlands in 156 
2007. As highlighted by C. Bleekers-Rovers (Nijmegen, Netherlands), due to a delay to 157 
implement measures and to environmental conditions favourable to bacterial dissemination, 158 
the epidemic expanded and more than 4000 cases have been identified to date [4]. The 159 
epidemic is now under control but clinicians currently face a subsequent huge outbreak of 160 
patients suffering from chronic Q fever. This long lasting Q fever epidemic has been a major 161 
opportunity to obtain precise information concerning the control of Q fever outbreaks, the 162 
diagnostic, the treatment of the disease and of course, the transmission of Coxiella, which may 163 
hopefully help public health actors and infectious diseases specialists to avoid another such 164 
large epidemic in the future. 165 
 166 
 167 
4) Clinical presentations, diagnostic approaches and treatments 168 
During all morning sessions, speakers detailed the clinical presentation of infections due 169 
to different intracellular bacteria and provided state of the art information on diagnosis 170 
approaches and treatment options of these infections. Thanks to the huge Dutch Q fever 171 
epidemic, a lot of information about Coxiella infections has been gathered [4]. As reported by C. 172 
Bleekers-Rovers (Nijmegen, Netherlands), the infection is symptomatic in only about 40% of 173 
infected people, that present generally with an acute Q fever. This infection is generally 174 
diagnosed by using PCR and/or serology, as underlined by O. Péter (Sion, Switzerland) and is 175 
resolved spontaneously within 2 or 3 weeks. Despite that, 1-5% of the patients develop a 176 
chronic Q fever, so it is necessary to treat acute Q fever for the patients at risk, with 177 
doxycycline 200 mg daily for 21 days. In case of chronic Q fever, the challenge is to early 178 
diagnose the infection. Indeed after an asymptomatic phase, severe complications occur with 179 
endocarditis as the most common manifestation, leading to high morbidity and mortality 180 
varying from 13% with a good treatment to 60% in absence of treatment. The recommended 181 
treatment is a long-term association of doxycycline and hydroxychloroquine, and the resection 182 
of the infected tissues. Two others intracellular bacteria play also a major role in the 183 
development of infectious endocarditis, Bartonella sp., and T. whipplei. Indeed, as explained by 184 
G. Greub (Lausanne, Switzerland), 14 species of Bartonella may infect humans, being 185 
responsible for several diseases such as Oroya fever (B. bacilliformis), cat scratch disease (B. 186 
henselae), trench fever (B. quitana) [5]. This infection is difficult to diagnose, so most of time it 187 
is better to use PCR, serology and/or histology. For uncomplicated cases there is no need of 188 
antibiotic, but for patients at risk or for specific clinical presentations, personalised antibiotic 189 
treatment might be used. T. whipplei are also responsible for endocarditis in case of localized 190 
chronic infection, but  in the majority (80%) of  the cases, the clinical manifestations are non 191 
specific, different organs can be targeted and when the gut is involved with associated weight 192 
loss, malabsorption syndrome and arthritis, we name this syndrome "classical Whipple's 193 
disease". (F. Fenollar, Marseille, France). The diagnosis is mainly based on PCR, and the 194 
treatment is empiric but long-term (for lifetime) association of doxycycline and 195 
hydroxychloroquine seems to be the ideal treatment.  196 
The diagnosis of blood culture negative endocarditis caused by T. whipplei and intracellular 197 
bacteria such as Bartonella and Coxiella is often difficult. Indeed, as reported by P-E Fournier 198 
(Marseille, France) (Fig. 2) blood culture being negative, it is necessary to use other diagnostic 199 
approaches such as PCR on blood and valves, serology and immunohistochemistry (or auto-200 
immunohistochemistry) on valves [6] [7]. Another interesting clinical characteristic of 201 
intracellular bacteria is the ability to induce adverse pregnancy outcomes [8]. D. Baud 202 
(Lausanne, Switzerland) (Fig. 2) summarized the role of some intracellular bacteria in humans' 203 
and/or animals' miscarriage, stillbirths, and preterm labour. Listeria monocytogenes is one of 204 
these bacteria. As described by M. Lecuit (Paris, France), this bacterium is very well known as 205 
an entheropathogen but it can also be responsible for septicemia, central nervous system 206 
infections, and maternal-foetal infections [9]. The diagnosis can be done by culture (blood, 207 
cerebro-spinal fluid, placenta,…), PCR, serology, and immunohistochemistry. The 208 
recommended treatment is amoxicillin combined to gentamicin for severe infections.  Among 209 
the other intracellular bacteria implicated in adverse pregnancy outcomes, the importance of 210 
Chlamydia and Chlamydia–related bacteria is increasingly recognised. D. Baud (Lausanne, 211 
Switzerland) exposed the characteristics of Chlamydia trachomatis infections that include 212 
trachoma and urogenital infections. These infections may be diagnosed by PCR or serology, and 213 
are best treated with doxycycline or azithromycin. D. Baud presented also some data about 214 
Waddlia chondrophila, a Chlamydia-related bacterium considered as an abortigenic agent in 215 
bovine, and associated with human adverse pregnancy outcomes [10] [11].   216 
 217 
5) Cell and molecular biology 218 
Several intracellular bacteria are human and animal pathogens. In order to understand 219 
mechanisms involved in their pathogenicity, it is essential to study the cellular and molecular 220 
biology of these pathogens. To enter, survive and grow within their host cells, intracellular 221 
bacteria need to evade the defence mechanisms of these host cells and to generate a replicative 222 
niche. As reported by A. Croxatto (Lausanne, Switzerland), secretion systems are one of the 223 
tools used by intracellular bacteria to interact with the host cell. Nowadays, seven secretion 224 
systems have been identified but Croxatto's talk was focusing on the Type Three Secretion  225 
System of the Chlamydiales and on the difficulty to identify its effectors. However, it is essential 226 
to identify these secreted effectors. Indeed, as explained by J. S. Dumler (Baltimore, USA), the 227 
pathogenesis of Anaplasmataceae infections is better understood since the identification of 228 
type II and type IV secretion systems effectors, which (i) interfere with host membrane traffic, 229 
(ii) interact with MAP kinase signalling pathway, and (iii) bind DNA in the nucleus leading to 230 
reduced the transcription of important genes [12]. Chlamydia pneumoniae are other 231 
intracellular bacteria using type III secretion system to modulate and interact with host cell 232 
signalling pathways. Within their inclusions, these bacteria are able to evade host defence 233 
mechanisms and to survive in a persistent stage resulting in a chronic infection. M. Puolakainen 234 
(Helsinki, Finland) (Fig. 2) described the particular way of life of these bacteria and the large 235 
panel of pathologies associated with chronic chlamydial infections. Always associated to 236 
Chlamydia pathogenesis, an important group of proteins specific to Chlamydia was described 237 
by D. Longbottom (Edinburgh, United Kingdom). The polymorphic membrane proteins (Pmps), 238 
are highly immunogenic and play an important role in bacterial virulence by acting as 239 
autotransporter proteins of the type V secretion system [13] [14]. Catalases are another key 240 
virulence factor for intracellular bacteria enabling their survival within phagocytic cells, but no 241 
catalase have been described so far in classical Chlamydia. B. Rusconi (Lausanne, Switzerland) 242 
showed the presence of genes encoding for catalases in Chlamydia-related bacteria and based 243 
on a phylogenetic analysis, she highlighted the important role of these catalases and their 244 
evolutionary history in the chlamydial order [15].  245 
Virulence is a key feature of intracellular bacteria, and the panel of strategies deployed by 246 
these bacteria is huge.  The Bartonella genus is composed of 14 pathogenic species, able to 247 
infect and multiply within endothelial cells and erythrocytes [16]. Then, as reported by P-E. 248 
Fournier(Marseille, France), these bacteria are able to promote angiogenesis allowing 249 
dissemination in the host organism, and are vectorized within erythrocytes, by insect vectors 250 
such as blood-sucking arthropods [16]. Rickettsiae are also transmitted by these arthropods, 251 
and then disseminated throughout the body via the bloodstream. These strict intracellular 252 
bacteria are able to infect a large panel of cells, but the main targets are endothelial cells. G. 253 
Greub (Lausanne, Switzerland) described their capability (i) to corrupt the host cells after 254 
escaping to the phagocytosis vacuole, (ii) to induce secretion of proinflammatory cytokines, 255 
and (iii) to inhibit apoptosis. Some intracellular bacteria are involved in several serious human 256 
pathogenesis such as Listeria. M. Lecuit (Paris, France) reported the dual roles of ActA protein 257 
involved in the virulence and persistence of Listeria during intestinal infections.  Moreover, he 258 
detailed the strategy used by Listeria, with the interaction between internalin and E-cadherin, 259 
to target and cross both intestinal and placental barriers [17]. Finally, pathogenesis induced by 260 
intracellular bacteria are sometimes very insidious. As explained by F. Fenollar (Marseille, 261 
France), it is the case for Tropheryma whipplei pathogenesis. Virtually nothing is known about 262 
these bacteria that seems to be opportunistic and might cause chronic infections among 263 
genetically predisposed patients.  264 
 265 
6) Genomics 266 
The Wednesday afternoon wad dedicated to talks about genomics of intracellular 267 
bacteria. Twenty years ago, it was the beginning of genome sequencing, and this tool is now 268 
used almost in routine. Nowadays, we are in a new genomic era focusing the advent of 269 
genomics of medical importance [18]. We have access to an ever increasing number of 270 
genomes and this provides significant information about intracellular bacteria. Genomics 271 
provides an insight in bacterial evolution and bacterial metabolism. Moreover, genomics is a 272 
very useful tool for research of new drugs or new drug targets, and provides information on 273 
the presence of a variety of virulence factors, including secretion systems, autotransporters, 274 
adhesins, and catalases. These virulence factors may be identified by various functional 275 
genomics approaches, as outlined by Marie de Barsy [19]. Lessons gathered from genomics of 276 
Listeria, Risckettsia, Chlamydia, and Chlamydia-related bacteria have been presented during 277 
this session. 278 
 279 
7) Practicals  280 
The last day of the workshop was dedicated to 9 different practicals (Fig. 3). They were 281 
organised at the Institute of Microbiology (IMUL) of the University Hospital Center (CHUV) and 282 
at the School of Medicine of the University of Lausanne.  283 
The main techniques for bacterial identification, isolation, staining and observation have 284 
been taught with a special focus on specific phenotypes and tools applied to intracellular 285 
bacteria, such as Legionella and Listeria. Participants had the opportunity to have some 286 
explanations about bacterial identification by MALDI-TOF 287 
Amoebal co-culture and amoebal enrichment have also been presented to the 288 
participants, to get them familiarized with approaches used to isolate amoeba-resisting 289 
microorganisms (ARM) and to recover free-living amoebae from clinical and environmental 290 
samples [20] [21]. To show how to obtain cells from different organisms, allowing further 291 
functional assays, isolation of mouse Bone Marrow-Derived Macrophages (BMDM) was shown. 292 
Ticks dissection was also explained in details. The importance of techniques allowing 293 
visualisation of infected cells or bacteria alone was highlighted by a detailed description of the 294 
immunofluorescence technique, as well as Gram and Diff-Quick stainings. Finally, bioinformatic 295 
tools useful for genome assembly and annotation were presented, emphasizing the importance 296 
of an interdisciplinary approach for biological data analysis. 297 
 298 
 299 
8) Conclusions 300 
 This Workshop, organised by Pr. Gilbert Greub on behalf of ESCAR, took place in the 301 
heart of the Swiss mountains, in a convivial environment, where biologists and clinicians had 302 
the possibility to meet, exchange ideas and learn about epidemiology, genomics, diagnosis and 303 
treatment of intracellular bacteria. The daily scientific program was brightened up by highly 304 
didactic and interesting clinical quizzes. Every day, participants were able to interact thanks to 305 
evening extra-activities such as ping-pong, swimming and running. Not less worthy was the 306 
Thursday afternoon, spent in mountains surrounding Villars-sur-Ollon. The next postgraduate 307 
technical workshop organised by ESCAR will be on the practical diagnosis of arthropod-borne 308 
infections, and will take place in Marseille (France) from 17th to 19th of March 2014. For sure, 309 
this will be another unique occasion to familiarize with intracellular bacteria, their intriguing 310 
biology and the important diseases they cause. 311 
 312 
9) Acknowledgements 313 
 314 
The ESCMID postgraduate technical workshop on intracellular bacteria: from 315 
biology to clinic was supported by the European Study Group on intracellular Bacteria 316 
(ESCAR), the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), and 317 
by the Center for Research on Intracellular Bacteria (CRIB). 318 
 319 
 320 
10) References 321 
[1] P. Parola, C.D. Paddock, C. Socolovschi, M.B. Labruna, O. Mediannikov, T. Kernif, et al., 322 
Update on tick-borne rickettsioses around the world: a geographic approach, Clin. 323 
Microbiol. Rev. 26 (2013) 657–702. 324 
[2] S. Stuen, D. Longbottom, Treatment and control of chlamydial and rickettsial infections 325 
in sheep and goats, Vet. Clin. North Am. Food Anim. Pract. 27 (2011) 213–233. 326 
[3] G. Dupuis, O. Péter, D. Pedroni, J. Petite, Aspects cliniques observés lors d'une épidémie 327 
de 415 cas de fièvre Q, Schweiz Med Wochenschr. 115 (1985) 814–818. 328 
[4] C.E. Delsing, B.J. Kullberg, C.P. Bleeker-Rovers, Q fever in the Netherlands from 2007 to 329 
2010, Neth J Med. 68 (2010) 382–387. 330 
[5] G.P. Wormser, G.S. Schleiter, Reemergence of Established Pathogens in the 21st Century 331 
Edited by I. W. Fong and Karla Drlica New York: Kluwer Academic/Plenum Publishers, 332 
2003. 367pp., Clinical Infectious Diseases. 39 (2004) 882–883. 333 
[6] G. Greub, H. Lepidi, C. Rovery, J.-P. Casalta, G. Habib, F. Collard, et al., Diagnosis of 334 
infectious endocarditis in patients undergoing valve surgery, The American Journal of 335 
Medicine. 118 (2005) 230–238. 336 
[7] P.-E. Fournier, F. Thuny, H. Richet, H. Lepidi, J.-P. Casalta, J.-P. Arzouni, et al., 337 
Comprehensive diagnostic strategy for blood culture-negative endocarditis: a 338 
prospective study of 819 new cases, Clinical Infectious Diseases. 51 (2010) 131–140. 339 
[8] D. Baud, G. Greub, Intracellular bacteria and adverse pregnancy outcomes, Clinical 340 
Microbiology and Infection. (2011). 341 
[9] M. Lecuit, Human listeriosis and animal models, Microbes and Infection. 9 (2007) 342 
1216–1225. 343 
[10] D. Baud, L. Regan, G. Greub, Emerging role of Chlamydia and Chlamydia-like organisms 344 
in adverse pregnancy outcomes, Curr. Opin. Infect. Dis. 21 (2008) 70–76. 345 
[11] D. Baud, V. Thomas, A. Arafa, L. Regan, G. Greub, Waddlia chondrophila, a potential 346 
agent of human fetal death, Emerging Infect. Dis. 13 (2007) 1239–1243. 347 
[12] J.S. Dumler, The biological basis of severe outcomes in Anaplasma phagocytophilum 348 
infection, FEMS Immunology & Medical Microbiology. 64 (2012) 13–20. 349 
[13] N. Wheelhouse, M. Sait, K. Wilson, K. Aitchison, K. McLean, D.G.E. Smith, et al., 350 
Expression patterns of five polymorphic membrane proteins during the Chlamydia 351 
abortus developmental cycle, Veterinary Microbiology. 160 (2012) 525–529. 352 
[14] N.M. Wheelhouse, M. Sait, K. Aitchison, M. Livingstone, F. Wright, K. McLean, et al., 353 
Processing of Chlamydia abortus polymorphic membrane protein 18D during the 354 
chlamydial developmental cycle, PLoS ONE. 7 (2012) e49190. 355 
[15] B. Rusconi, G. Greub, Discovery of catalases in members of the Chlamydiales order, J. 356 
Bacteriol. 195 (2013) 3543–3551. 357 
[16] G. Greub, D. Raoult, Bartonella: new explanations for old diseases, (2002). 358 
[17] M. Bonazzi, M. Lecuit, P. Cossart, Listeria monocytogenes internalin and E-cadherin: 359 
from bench to bedside, Cold Spring Harb Perspect Biol. 1 (2009) a003087. 360 
[18] C. Bertelli, G. Greub, Rapid bacterial genome sequencing: methods and applications in 361 
clinical microbiology, Clin. Microbiol. Infect. 19 (2013) 803–813. 362 
[19] M. de Barsy, G. Greub, Functional genomics of intracellular bacteria, Brief Funct 363 
Genomics. 12 (2013) 341–353. 364 
[20] N. Jacquier, S. Aeby, J. Lienard, G. Greub, Discovery of new intracellular pathogens by 365 
amoebal coculture and amoebal enrichment approaches, J Vis Exp. (2013) e51055. 366 
[21] J. Lienard, G. Greub, Discovering new pathogens: amoebae as tools to isolate Amoebae-367 
resisting to isolate microorganisms from environmental samples in: Environmental 368 
Microbiology: Current Technology and Water Applications , Norfolk, UK : Caister 369 
Academic Press, (2011). 370 
 371 
 372 
 373 
Figure legend 374 
 Figure 1: Participants and venue. The top part is on overview of the hiking in the Swiss 375 
pastures. On the bottom left, the small but motivated group of early risers joggers, and on the 376 
bottom right, the friendly atmosphere that was present during lunch and diner.  377 
 378 
 Figure 2: Talks and speakers. On the top left, the beautiful presentation room with 379 
attentive participants, and three of the speakers, (i) Dr. M. Puolakainen (Helsinki, Finland), (ii) 380 
Dr. P.E. Fournier (Marseille, France), and (iii) Dr. D. Baud (Lausanne, Switzerland). 381 
 382 
 Figure 3: Practicals. An overview of the nine practicals organized in the Institute of 383 
microbiology of the University Hospital Center of Lausanne (IMUL-CHUV). From top to the 384 
bottom and left to the right: (1) dissection of ticks, (2) Listeria, phenotypes and phenotypic 385 
identification in the diagnostic laboratory, (3) amoebal enrichment, (4) immunofluorescence, 386 
(5) amoebal co-culture, (6) cell culture: isolation of bone marrow-derived macrophages, (7) 387 
doing a Gram and Diff-Quick staining, (8) bioinformatics for dummies: how to assemble a 388 
genome and how to annotate a genome, and (9) MALDI-TOF identification of strict intracellular 389 
bacteria: the Chlamydiales example. 390 
 391 
 392 
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